DSM-Firmenich
€97.58Change from previous close: −0.45%Absolute change: −€0.44
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €23.5B
- Enterprise value
- €28.65B
- P/E (trailing 12 months)
- 68.6
- Forward P/E
- 23.4
- PEG
- 0.73
- Price/book
- 1.35
- Price/sales
- 2.60
- EV/EBITDA
- 21.9
- EV/revenue
- 3.16
Profitability and growth
- Gross margin
- 39.2%
- Operating margin
- 7.9%
- Net margin
- -15.2%
- ROE
- 1.9%
- ROA
- 1.2%
- Revenue growth (year over year)
- 0.5%
- Earnings growth (year over year)
- -56.2%
Financial health
- Total cash
- €2.31B
- Total debt
- €6.77B
- Debt/equity
- 0.38
- Current ratio
- 1.75
- Quick ratio
- 0.82
Dividends
- Annual dividend per share
- €2.50
- Dividend yield
- 2.6%
- Payout ratio
- 178.6%
- Ex-dividend date
- May 11, 2026
Analysts and estimates
- Average price target
- €94.22
- Median price target
- €96.50
- High price target
- €117.00
- Low price target
- €67.00
- Analysts with a price target
- 20
- Consensus
- Buy
- Forward EPS
- €4.11
- EPS estimate, current year
- €3.61
Shares and trading
- Beta
- 0.57
- Average volume
- 733.79K
- Shares outstanding
- 244.55M
- Float
- 217.04M
- Institutional ownership
- 51.6%
- Insider ownership
- 9.5%